Here's How Much $100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today

Why was Jane Street banned in India? How will Trump’s big bill impact Medicaid? What caused the recent surge in Nvidia stock? Why are US electric vehicle tax credits ending? How did the US-Vietnam trade deal affect tariffs? What’s behind Meta’s AI talent recruitment spree? Why are layoffs increasing in tech companies?

Here's How Much $100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today

benzinga.com/insights/news/25/07/46207133/heres-how-much-100-invested-in-regeneron-pharmaceuticals-20-years-ago-would-be-worth-today

Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 13.87% on an annualized basis producing an average annual return of 22.35%. Currently, Regeneron Pharmaceuticals has a market capitalization of $56.34 billion.
Buying $100 In REGN: If ...
Full…

This story appeared on benzinga.com, 2025-07-01 20:01:27.